Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Artificial intelligence continues to capture the attention of lawmakers and regulators not only as an important focus of oversight, but also as a tool to be harnessed to help perform such oversight. We look at some key AI items captured by Pathways Document Depot over the past two months.
Left atrial appendage closure is a well-validated treatment to prevent stroke in AFib patients, but current device options do not allow physicians to streamline their practices to their needs. Conformal Medical’s CLAAS device, now in a large, randomized pivotal trial, was created to address a market ripe with growth while supporting greater case volumes and safer outcomes.
Gene and cell therapies have curative potential for some inherited genetic diseases, but technologies for rapid screening and diagnosis of genetic variants are a prerequisite. An excerpt from our recent interview with Stephen Kingsmore, who is at the forefront of making pediatric genomic testing and newborn screening universal and accessible.